LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Therapeutics HiberCell specializes in novel agents targeting stress pathways and anti-tumor immunity, presenting an opportunity to collaborate with healthcare providers looking for cutting-edge oncology treatments.

Expansion & Acquisitions Recent acquisitions like Genuity Science, Inc. demonstrate HiberCell's growth trajectory, indicating potential partnership opportunities for companies seeking to leverage advanced genomics and AI platforms in oncology research.

Key Personnel Expertise The addition of industry experts like Cindy Jacobs and Mark J. Mulvihill to HiberCell's leadership team enhances the company's scientific capabilities, offering a partnership avenue for organizations seeking collaborations with experienced professionals in biotechnology research.

Product Pipeline Development With products like HC-5404-FU in development targeting cancer relapse and metastasis, HiberCell presents an opportunity for biopharmaceutical companies interested in co-developing or licensing innovative therapeutic solutions to enhance their product portfolio.

Financial Stability & Growth HiberCell's healthy revenue and substantial funding of $67M indicate financial stability, making it an attractive partner for investors or organizations seeking joint ventures with a well-funded biotechnology company poised for growth.

Similar companies to HiberCell

HiberCell Tech Stack

HiberCell uses 8 technology products and services including Amazon S3, Font Awesome, Twitter Emoji (Twemoji), and more. Explore HiberCell's tech stack below.

  • Amazon S3
    Content Delivery Network
  • Font Awesome
    Font Scripts
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Typekit
    Font Scripts
  • jQuery UI
    Javascript Libraries
  • Buildout
    Real Estate Marketing
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks

Media & News

HiberCell's Email Address Formats

HiberCell uses at least 1 format(s):
HiberCell Email FormatsExamplePercentage
FLast@hibercell.comJDoe@hibercell.com
93%
FirLast@hibercell.comJohDoe@hibercell.com
3%
LastFi@hibercell.comDoeJo@hibercell.com
2%
Last.First@hibercell.comDoe.John@hibercell.com
2%

Frequently Asked Questions

Where is HiberCell's headquarters located?

Minus sign iconPlus sign icon
HiberCell's main headquarters is located at 619 West 54th Street 8th Floor New York, New York 10019 US. The company has employees across 2 continents, including North AmericaAfrica.

What is HiberCell's official website and social media links?

Minus sign iconPlus sign icon
HiberCell's official website is hibercell.com and has social profiles on LinkedIn.

How much revenue does HiberCell generate?

Minus sign iconPlus sign icon
As of September 2024, HiberCell's annual revenue reached $15M.

What is HiberCell's SIC code NAICS code?

Minus sign iconPlus sign icon
HiberCell's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does HiberCell have currently?

Minus sign iconPlus sign icon
As of September 2024, HiberCell has approximately 51 employees across 2 continents, including North AmericaAfrica. Key team members include Chief Medical Officer: C. T. T.Chief Scientific Officer: N. B.Vice President Clinical Operations/ Program Management: M. G.. Explore HiberCell's employee directory with LeadIQ.

What industry does HiberCell belong to?

Minus sign iconPlus sign icon
HiberCell operates in the Biotechnology Research industry.

What technology does HiberCell use?

Minus sign iconPlus sign icon
HiberCell's tech stack includes Amazon S3Font AwesomeTwitter Emoji (Twemoji)TypekitjQuery UIBuildoutGoogle Tag ManagerBootstrap.

What is HiberCell's email format?

Minus sign iconPlus sign icon
HiberCell's email format typically follows the pattern of . Find more HiberCell email formats with LeadIQ.

How much funding has HiberCell raised to date?

Minus sign iconPlus sign icon
As of September 2024, HiberCell has raised $67M in funding. The last funding round occurred on May 19, 2021 for $67M.

When was HiberCell founded?

Minus sign iconPlus sign icon
HiberCell was founded in 2019.
HiberCell

HiberCell

Biotechnology ResearchNew York, United States51-200 Employees

HiberCell is a clinical stage oncology company, dedicated to the advancement of first-in-class agents with the novel MOA of modulation of adaptive stress pathways and anti-tumor immunity. We believe that therapeutic modulation of these mechanisms allows us to address tumor metastasis, treatment resistance, and cancer relapse; all significant drivers of cancer-related deaths. Our product candidates HC-5404 and HC-7366, both completing Phase 1a clinical trials, target the stress response kinases PERK and GCN2, respectively, while our product candidate odetiglucan, currently in Phase 2 clinical development, modulates the anti-tumor innate immune response.

Section iconCompany Overview

Headquarters
619 West 54th Street 8th Floor New York, New York 10019 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $67M

    HiberCell has raised a total of $67M of funding over 3 rounds. Their latest funding round was raised on May 19, 2021 in the amount of $67M.

  • $10M$50M

    HiberCell's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $67M

    HiberCell has raised a total of $67M of funding over 3 rounds. Their latest funding round was raised on May 19, 2021 in the amount of $67M.

  • $10M$50M

    HiberCell's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.